Brief: Liminal BioSciences Reports Receipt Of Nasdaq Deficiency Notice Regarding Minimum Bid Price Requirement
07/03/2022 22:01
March 7 (Reuters) - Liminal BioSciences Inc LMNL.O :
* LIMINAL BIOSCIENCES ANNOUNCES RECEIPT OF NASDAQ DEFICIENCY
NOTICE REGARDING MINIMUM BID PRICE REQUIREMENT
Source text for Eikon: ID:nPnccw0fVa
Further company coverage: LMNL.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Liminal BioSciences
See all newsBrief: Liminal Biosciences Announces Completion Of The Plan Of Arrangement With Structured Alpha Lp
Brief: Liminal Biosciences Files Amended Schedule 13E-3 And Supplement To Management Information Circular
Brief: Liminal Biosciences Obtains Interim Order For Proposed Arrangement With Structured Alpha Lp
U.S. STOCKS ON THE MOVE-Liminal Biosciences, Tesla, Quad/Graphics
U.S. STOCKS ON THE MOVE-T2 Biosystems, GoodRx Holdings, ShiftPixy